CAS 828934-41-4

2-Oxiranecarboxylic acid, 2-[6-(4-chlorophenoxy)hexyl]-, sodium salt (1:1), (2R)-

Description:

2-Oxiranecarboxylic acid, 2-[6-(4-chlorophenoxy)hexyl]-, sodium salt (1:1), (2R)-, is a chemical compound characterized by its unique structure that includes an epoxide group (oxirane) and a carboxylic acid functional group. The presence of the sodium salt indicates that the compound is likely soluble in water, which can enhance its utility in various applications, such as in pharmaceuticals or agrochemicals. The 4-chlorophenoxy group contributes to its hydrophobic characteristics, potentially influencing its biological activity and interaction with other molecules. The compound's stereochemistry, indicated by the (2R) designation, suggests specific spatial arrangements that can affect its reactivity and interactions in biological systems. Overall, this compound may exhibit interesting properties due to its combination of functional groups, making it a subject of interest for further research in fields such as medicinal chemistry or materials science.

Formula: C₁₅H₁₉ClO₄·Na

InChI: InChI=1S/C15H19ClO4.Na/c16-12-5-7-13(8-6-12)19-10-4-2-1-3-9-15(11-20-15)14(17)18;/h5-8H,1-4,9-11H2,(H,17,18);/t15-;/m1./s1

InChI key: InChIKey=ZUMIFLJZQDMWAU-XFULWGLBSA-N

SMILES: C(CCCCCOC1=CC=C(Cl)C=C1)[C@]2(C(O)=O)CO2.[Na]

Synonyms:

• (+)-Etomoxir Sodium Hydrate
• (+)-Etomoxir hydrate sodium salt
• 2-Oxiranecarboxylic acid, 2-[6-(4-chlorophenoxy)hexyl]-, sodium salt (1:1), (2R)-
• Anti-eapii (ttrap)
• Oxiranecarboxylic acid, 2-[6-(4-chlorophenoxy)hexyl]-, sodium salt, (2R)-
• R(+)-2-[6-(4-Chlorophenoxy)Hexyl]-Oxirane-2-Carboxylic Acid Sodium Salt Hydrate
• R(+)-2-[6-(4-Chlorophenoxy)hexyl]-oxirane-2-carboxylic
• sodium (2R)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate hydrate

Etomoxir sodium salt

CAS: 828934-41-4

Etomoxir sodium salt

Purity: ≥98%

Molecular weight: 320.74g/mol

Ref: 54-BUP10353

(R)-(+)-Etomoxir sodium

CAS: 828934-41-4

(R)-(+)-Etomoxir sodium

Purity: 98%

Molecular weight: 320.74g/mol

Ref: 54-BISN0105

Etomoxir Impurity 1 Sodium Salt

CAS: 828934-41-4

Formula: C₁₅H₁₈ClO₄·Na

Molecular weight: 297.76 22.99

Ref: 4Z-E-232004

(+)-Etomoxir sodium salt hydrate

CAS: 828934-41-4

Formula: C₁₅H₁₈ClO₄·Na·H₂O

Purity: (HPLC) ≥ 98.0%

Color and Shape: White powder

Molecular weight: 338.76

Ref: 7W-GL0593

Etomoxir Impurity 1-13C6 Sodium Salt

CAS: 828934-41-4

Formula: C₉₁₃C₆H₁₈ClO₄·Na

Molecular weight: 303.71

Ref: 4Z-E-232005

Etomoxir sodium salt

CAS: 828934-41-4

Etomoxir sodium salt ((R)-Etomoxir sodium salt) is a carnitine palmitoyltransferase 1a (CPT-1a) inhibitor that blocks fatty acid synthesis.

Formula: C₁₅H₁₈ClO₄·Na

Purity: 99.34% - 99.82%

Color and Shape: Solid

Molecular weight: 320.74

Ref: TM-T4535

Sodium (R)-2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate

CAS: 828934-41-4

Formula: C₁₅H₁₈ClNaO₄

Purity: 98%

Color and Shape: Liquid, No data available.

Molecular weight: 320.74

Ref: 10-F516300

(2R)-2-[6-(4-Chlorophenoxy)hexyl]-oxiranecarboxylic Acid Sodium Salt

Controlled Product

CAS: 828934-41-4

Applications (2R)-2-[6-(4-Chlorophenoxy)hexyl]-oxiranecarboxylic Acid Sodium Salt is a carnitine palmatoyltransferase 1 inhibitor. It is also a chemo-sensitizing agent that is able to induce apoptosis in HL60 cells when used with glycolytic inhibitors such as 2-deoxy-D-glucose (D239000) and lonidamine (L469458).
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Estan, M. C., et al.: PLoS One. 9, e115250 (2014); Li, A. J., et al.: Am J Physiol Regul Integr Comp Physiol. 310, R724 (2016)

Formula: C₁₅H₁₈ClO₄·Na

Color and Shape: White To Off-White

Molecular weight: 320.744

Ref: TR-C433080

(2R)-2-[6-(4-Chlorophenoxy)hexyl]-2-oxiranecarboxylic acid sodium

CAS: 828934-41-4

(+)-Etomoxir sodium salt hydrate is a chemical compound classified as a carnitine palmitoyltransferase 1 (CPT1) inhibitor, which is a compound derived synthetically. Its mode of action involves the inhibition of the enzyme CPT1, which is pivotal in the transport of long-chain fatty acids into the mitochondria for β-oxidation. This inhibition effectively blocks fatty acid oxidation pathways, leading to alterations in metabolic states.Etomoxir is commonly utilized in scientific research to study metabolic processes, particularly those related to energy metabolism and metabolic disorders. It serves as a valuable tool in exploring mechanisms involved in diabetes, obesity, and cardiovascular diseases by allowing researchers to scrutinize the metabolic adaptations to impaired fatty acid oxidation. Furthermore, it is used in cellular and animal models to investigate metabolic inflexibility and mitochondrial function. Its application extends to cancer research, where metabolic reprogramming is a focus, aiding in the understanding of tumor progression and potential therapeutic interventions targeting metabolic pathways.

Formula: C₁₅H₁₈ClNaO₄

Molecular weight: 320.74 g/mol

Ref: 3D-BE164435